The company has received a warning letter from the US Food and Drug Administration (FDA) over inadequate quality control procedures at three of its drug manufacturing plants in Srikakulam, Miryalaguda and Duvvada.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
